Print Page   |   Contact Us   |   Report Abuse   |   Sign In   |   Join Now
Site Search
The Role of the Health-System Pharmacist in Safely and Effectively Treating Direct Oral Anticoagulan
Tell a Friend About This EventTell a Friend

When: Thursday, July 11, 2019
7:00 PM
Where: Season2 52
5096 Big Island Drive
Jacksonville, Florida 
United States

Online registration is closed.
« Go to Upcoming Event List  

This Continuing Education Program is Sponsored and Accredited by Pharmacy Times

Accredited for pharmacists


July 11, 2019

7:00 PM

Seasons 52, 5096 Big Island Drive, Jacksonville, FL 32246


The Role of the Health-System Pharmacist in Safely and Effectively Treating Direct Oral Anticoagulant Bleeding with Novel Reversal Agents by James S. Kalus, PharmD, FASHP, Director of Pharmacy, Henry Ford Health System, Detroit, MI

Learning Objectives:

   Examine the incidence of major bleeding associated with the use of DOACs and the need for availability of reversal agents to prevent complications

   Identify the risk factors and patient populations at high risk for bleeding complications due to use of DOACs.

   Analyze the mechanisms of action, safety and efficacy, and adverse effects associated with the use of current and emerging DOAC reversal agents for FXa inhibitors

   Explore the role of the health-system pharmacist in improving patient outcomes via clinical recommendations regarding the proper use of DOAC reversal agents and in anticoagulation monitoring protocols


Activity Overview:

Direct oral anticoagulants (DOACs) are increasingly being used in practice for the treatment of venous thromboembolism and prevention of stroke in patients with nonvalvular atrial fibrillation. A major adverse effect related to use of DOACs is bleeding that has the potential to be life threatening or fatal. It is important for pharmacists to understand the risk factors and definition of major bleeding as well as assessment and management strategies for patients who present with bleeding. The goal of this activity is to review the efficacy and safety of various available reversal agents as well as dosing, preparation, and administration. We will discuss the role of the pharmacist in helping to facilitate the appropriate use of these agents through creation and implementation of hospital-specific protocols for DOAC reversal.


RSVP by July 3rd


Featured Members
Meghan J. ArwoodDedication and contributions to NCFSHP Regional Society
Karen Sando2019 FSHP Pharmacist of the Year award recipient

Membership Management Software Powered by YourMembership  ::  Legal